MENU

VRDN Viridian Therapeutics Forecast, Technical & Fundamental Analysis

a developer of biopharmaceuticals

Industry Biotechnology
VRDN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VRDN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

VRDN is expected to report earnings to fall 9.57% to -103 cents per share on February 26

Viridian Therapeutics VRDN Stock Earnings Reports
Q4'24
Est.
$-1.04
Q3'24
Missed
by $0.09
Q2'24
Missed
by $0.15
Q1'24
Beat
by $0.30
Q4'23
Missed
by $0.37
The last earnings report on November 12 showed earnings per share of -114 cents, missing the estimate of -105 cents. With 2.08M shares outstanding, the current market capitalization sits at 1.65B.
A.I. Advisor
published General Information

General Information

a developer of biopharmaceuticals

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
221 Crescent Street
Phone
+1 617 272-4600
Employees
94
Web
https://www.viridiantherapeutics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME31.261.82
+6.18%
GameStop Corp
TSLA479.8616.84
+3.64%
Tesla
AAPL253.482.44
+0.97%
Apple
BTC.X106140.600000110.890625
+0.10%
Bitcoin cryptocurrency
SPY604.29-2.50
-0.41%
SPDR® S&P 500® ETF Trust

VRDN and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, VRDN has been loosely correlated with ALLO. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if VRDN jumps, then ALLO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VRDN
1D Price
Change %
VRDN100%
+20.67%
ALLO - VRDN
54%
Loosely correlated
+8.99%
FATE - VRDN
49%
Loosely correlated
+9.29%
AURA - VRDN
47%
Loosely correlated
+5.71%
CRBU - VRDN
47%
Loosely correlated
N/A
ABCL - VRDN
45%
Loosely correlated
+1.78%
More